0001157523-20-000395.txt : 20200319 0001157523-20-000395.hdr.sgml : 20200319 20200319163756 ACCESSION NUMBER: 0001157523-20-000395 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20200319 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20200319 DATE AS OF CHANGE: 20200319 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Acadia Healthcare Company, Inc. CENTRAL INDEX KEY: 0001520697 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-35331 FILM NUMBER: 20728995 BUSINESS ADDRESS: STREET 1: 6100 TOWER CIRCLE STREET 2: SUITE 1000 CITY: FRANKLIN STATE: TN ZIP: 37067 BUSINESS PHONE: 615-861-6000 MAIL ADDRESS: STREET 1: 6100 TOWER CIRCLE STREET 2: SUITE 1000 CITY: FRANKLIN STATE: TN ZIP: 37067 8-K 1 a52191939.htm ACADIA HEALTHCARE COMPANY, INC. 8-K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC  20549
______________________________

FORM 8-K

CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): March 19, 2020
______________________________

Acadia Healthcare Company, Inc.
(Exact Name of Registrant as Specified in Its Charter)

Delaware
  
001-35331
  
45-2492228
(State or Other Jurisdiction of Incorporation)
  
(Commission File Number)
  
(IRS Employer Identification No.)

6100 Tower Circle, Suite 1000
Franklin, Tennessee
(Address of Principal Executive Offices)
 
37067
(Zip Code)

(615) 861-6000
(Registrant’s Telephone Number, including Area Code)

Not Applicable
(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (See General Instruction A.2. below):

☐  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class
  
Trading Symbol
  
Name of each exchange on which registered
Common Stock, $0.01 par value
  
ACHC
  
NASDAQ Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company
☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.             ◻


 Item 2.02
 
 Results of Operations and Financial Condition.

On March 19, 2020, Acadia Healthcare Company, Inc. (“Acadia”) issued a press release providing a business update on the Company’s operations relating to the COVID-19 pandemic and the potential sale of the Company’s U.K. operations.  The press release is furnished herewith as Exhibit 99 hereto and is incorporated herein by reference.

 Item 9.01
 
 Financial Statements and Exhibits.
 
 
 
 (d)
 
 Exhibits.
 
 
 
 
     
 104
 
 Cover Page Interactive Data File (embedded within the Inline XBRL document)
   

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


 
ACADIA HEALTHCARE COMPANY, INC.
  
     
     
   
 
Date:  March 19, 2020
By:
/s/ Christopher L. Howard  
    Christopher L. Howard  
    Executive Vice President and General Counsel  
       

EX-99 2 a52191939ex99.htm EXHIBIT 99.1
 
 Exhibit 99

Acadia Healthcare Provides Business Update

FRANKLIN, Tenn.--(BUSINESS WIRE)--March 19, 2020--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today provides a business update to investors in light of the ongoing market environment.

Debbie Osteen, Chief Executive Officer of Acadia Healthcare Company, remarked, “Today, we face an unprecedented global event with the COVID-19 pandemic. Though we do not know exactly how this situation will unfold, we are carefully monitoring the impact to our business and believe Acadia is well-positioned to support our patient population and continue to grow our business. The health and safety of our staff, patients and visitors are always our top priorities, and we have implemented recommended precautionary measures throughout our operations. We have strong local leadership and staff in our facilities who continue to support and provide our patients with high-quality care every day. We believe the demand for mental health and substance use treatment is not discretionary or elective. We continue to see demand across our services lines consistent with our expectations.

“As we disclosed when we announced financial results on February 27, 2020, we commenced a formal process regarding the sale of our U.K. business in January and received multiple indications of interest. While the interest from potential buyers remains strong, given evolving market dynamics related to the COVID-19 pandemic, we have decided to temporarily suspend the sale process until market conditions improve. Our objective continues to be maximizing value for our stockholders. At this time, our focus is on serving our patients in the U.K. to the very best of our ability and ensuring the safety and health of our employees.

“Our balance sheet remains strong, and we have adequate liquidity and capital to invest in and grow our business. Acadia had $90 million in cash and cash equivalents and full availability under its $500 million revolving credit facility as of February 29, 2020.

“As we emerge from this difficult time, we believe our services will be in greater need, and we will be very well-positioned to meet that demand,” added Osteen.

About Acadia

Acadia is a leading provider of behavioral healthcare services. At December 31, 2019, Acadia operated a network of 585 behavioral healthcare facilities with approximately 18,200 beds in 40 states, the United Kingdom and Puerto Rico. Acadia provides behavioral health and addiction services to its patients in a variety of settings, including inpatient psychiatric hospitals, specialty treatment facilities, residential treatment centers and outpatient clinics.

Forward-Looking Information

This news release contains forward-looking statements. Generally, words such as “may,” “will,” “should,” “could,” “anticipate,” “expect,” “intend,” “estimate,” “plan,” “continue,” and “believe” or the negative of or other variation on these and other similar expressions identify forward-looking statements. These forward-looking statements are made only as of the date of this news release. We do not undertake to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise. Forward-looking statements are based on current expectations and involve risks and uncertainties and our future results could differ significantly from those expressed or implied by our forward-looking statements. Factors that may cause actual results to differ materially include, without limitation, (i) the impact of the COVID-19 pandemic; (ii) potential difficulties operating our business in light of political and economic instability in the U.K. and globally relating to the U.K.’s departure from the European Union; (iii) the impact of fluctuations in foreign exchange rates, including the devaluation of the British Pound Sterling (GBP) relative to the U.S. Dollar (USD); (iv) Acadia’s efforts to sell its U.K. operations may not result in any definitive transaction or enhance stockholder value; (v) potential difficulties in successfully integrating the operations of acquired facilities or realizing the expected benefits and synergies of our acquisitions, joint ventures and de novo transactions; (vi) Acadia’s ability to add beds, expand services, enhance marketing programs and improve efficiencies at its facilities; (vii) potential reductions in payments received by Acadia from government and commercial payors; (viii) the occurrence of patient incidents, governmental investigations and adverse regulatory actions, which could adversely affect the price of our common stock and result in substantial payments and incremental regulatory burdens; (ix) the risk that Acadia may not generate sufficient cash from operations to service its debt and meet its working capital and capital expenditure requirements; and (x) potential operating difficulties, labor costs, client preferences, changes in competition and general economic or industry conditions that may prevent Acadia from realizing the expected benefits of its business strategies. These factors and others are more fully described in Acadia’s periodic reports and other filings with the SEC.

Contacts

Gretchen Hommrich
Director, Investor Relations
(615) 861-6000

EX-101.SCH 3 achc-20200319.xsd XBRL TAXONOMY EXTENSION SCHEMA 000100 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 achc-20200319_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Amendment Flag City Area Code Entity Address, City or Town Entity Address, Country Document Period End Date Entity Incorporation, State or Country Code Entity Information, Former Legal or Registered Name Local Phone Number Entity Address, Postal Zip Code Entity Address, State or Province Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Entity Registrant Name Entity Central Index Key Entity Tax Identification Number Document Fiscal Year Focus Document Fiscal Period Focus Document Type Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Entity File Number Entity Emerging Growth Company EX-101.PRE 5 achc-20200319_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 7 a52191939_htm.xml IDEA: XBRL DOCUMENT 0001520697 2020-03-19 2020-03-19 false 0001520697 8-K 2020-03-19 Acadia Healthcare Company, Inc. DE 001-35331 45-2492228 6100 Tower Circle Suite 1000 Franklin TN 37067 615 861-6000 Not Applicable false false false false Common Stock, $0.01 par value ACHC NASDAQ false EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 10 R1.htm IDEA: XBRL DOCUMENT v3.20.1
Document and Entity Information
Mar. 19, 2020
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Mar. 19, 2020
Entity Registrant Name Acadia Healthcare Company, Inc.
Entity Incorporation, State or Country Code DE
Entity File Number 001-35331
Entity Tax Identification Number 45-2492228
Entity Address, Address Line One 6100 Tower Circle
Entity Address, Address Line Two Suite 1000
Entity Address, City or Town Franklin
Entity Address, State or Province TN
Entity Address, Postal Zip Code 37067
City Area Code 615
Local Phone Number 861-6000
Entity Information, Former Legal or Registered Name Not Applicable
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Entity Central Index Key 0001520697
Title of 12(b) Security Common Stock, $0.01 par value
Trading Symbol ACHC
Security Exchange Name NASDAQ
XML 11 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} JSON 12 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "a52191939.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "definitionLink": { "remote": [ "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-eedm-def-2019-01-31.xml", "http://xbrl.fasb.org/srt/2019/elts/srt-eedm1-def-2019-01-31.xml" ] }, "inline": { "local": [ "a52191939.htm" ] }, "labelLink": { "local": [ "achc-20200319_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "achc-20200319_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml" ] }, "schema": { "local": [ "achc-20200319.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-roles-2019-01-31.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-2019-01-31.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-types-2019-01-31.xsd", "http://xbrl.fasb.org/srt/2019/elts/srt-roles-2019-01-31.xsd", "https://xbrl.sec.gov/country/2017/country-2017-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2019/elts/us-types-2019-01-31.xsd", "https://xbrl.sec.gov/currency/2019/currency-2019-01-31.xsd", "https://xbrl.sec.gov/exch/2019/exch-2019-01-31.xsd", "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd", "https://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd", "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd", "http://www.xbrl.org/2004/ref-2004-08-10.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 30, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2019-01-31": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 95, "memberCustom": 0, "memberStandard": 0, "nsprefix": "achc", "nsuri": "http://acadiahealthcare.com/20200319", "report": { "R1": { "firstAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "a52191939.htm", "contextRef": "c20200319to20200319", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000100 - Document - Document and Entity Information", "role": "http://acadiahealthcare.com/role/DocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "body", "html" ], "baseRef": "a52191939.htm", "contextRef": "c20200319to20200319", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://acadiahealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://acadiahealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "xbrltype": "stringItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://acadiahealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://acadiahealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://acadiahealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://acadiahealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://acadiahealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://acadiahealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://acadiahealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://acadiahealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://acadiahealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://acadiahealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://acadiahealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://acadiahealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://acadiahealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://acadiahealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://acadiahealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInformationFormerLegalOrRegisteredName": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Former Legal or Registered Name of an entity", "label": "Entity Information, Former Legal or Registered Name" } } }, "localname": "EntityInformationFormerLegalOrRegisteredName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://acadiahealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://acadiahealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://acadiahealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://acadiahealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://acadiahealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://acadiahealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://acadiahealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://acadiahealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://acadiahealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://acadiahealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://acadiahealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://acadiahealthcare.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } XML 13 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.1 html 1 95 1 false 0 0 false 0 false false R1.htm 000100 - Document - Document and Entity Information Sheet http://acadiahealthcare.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports a52191939.htm a52191939ex99.htm achc-20200319.xsd achc-20200319_lab.xml achc-20200319_pre.xml http://xbrl.sec.gov/dei/2019-01-31 true false ZIP 14 0001157523-20-000395-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001157523-20-000395-xbrl.zip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end